Ares Capital Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARCC research report →
Range $19 – $22
Price Chart
About the company
Ares Capital Corporation (ARCC) operates as a Business Development Company (BDC), delivering diverse financing solutions predominantly to middle-market enterprises. The firm's expertise lies in facilitating various corporate actions, including funding acquisitions, recapitalizations, and leveraged buyouts. It also extends mezzanine debt, assists with corporate restructurings, and provides crucial rescue financing, in addition to offering growth capital and general refinancing options.
- CEO
- Kort Schnabel
- IPO
- 2004
- Employees
- 4,250
- HQ
- Los Angeles, CA, US
Get TickerSpark's AI analysis on ARCC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $13.31B
- P/E
- 15.43
- Fwd P/E
- 9.75
- PEG
- -0.40
- P/S
- 5.62
- P/B
- 0.97
- EV/EBITDA
- 16.03
- Div Yield
- 10.20%
- Gross Margin
- 68.68%
- Op Margin
- 65.25%
- Net Margin
- 36.16%
- ROE
- 6.23%
- ROIC
- 4.89%
Latest fiscal year · YoY change
- Revenue
- $2.24B-5.3%
- Gross Profit
- $1.51B-11.8%
- Op Income
- $1.40B
- Net Income
- $1.30B-14.7%
- EPS
- $1.86-23.8%
- OCF Growth
- -10.9%
- FCF Growth
- -10.9%
- 52W High
- $21.14
- 52W Low
- $17.40
- 50D MA
- $19.01
- 200D MA
- $18.94
- Beta
- 0.64
- RSI (14)
- 38
- Avg Volume
- 4.43M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Ares Capital delivered steady third-quarter earnings, kept credit quality stable, and announced a strategically important but only modestly accretive acquisition of MidCap Financial Investment Corporation.· October 27, 2026
- Core EPS was $0.46 and GAAP EPS was $0.44; NAV was $19.31 per share, down $0.04 quarter over quarter.
- Credit stayed solid: nonaccruals were unchanged at 2.4% of cost and 1.4% of fair value, with loan-to-value around 47%.
- The company announced an agreement to acquire MFIC, which management said should be modestly accretive and expand the portfolio to over 800 companies.
- Funding and liquidity remain strong, with net leverage at 1.06x, about $7 billion of available liquidity pro forma, and a new $750 million unsecured note issue at 185 basis points over treasuries.
- Management said origination slowed because of both greater selectivity and a slower deal market, but backlog was still about $2.5 billion and $1.1 billion had already closed in the fourth quarter.
Ares Capital reported third-quarter 2026 core earnings of $0.46 per share, compared with $0.47 in the prior quarter, and GAAP net income of $0.44 per share versus $0.24 in the second quarter of 2026. Total portfolio fair value was $29.2 billion, down slightly from $29.3 billion sequentially, and NAV ended at $13.9 billion, or $19.31 per share, down $0.04 per share quarter over quarter. Net leverage was 1.06x debt-to-equity versus 1.12x last quarter. Management said every 100 basis point increase in base rates would add about $0.02 per share of quarterly earnings, with the benefit expected to start showing in the fourth quarter. For the fourth quarter of 2026, the regular dividend was set at $0.48 per share, payable December 29; spillover income was $983 million, or $1.37 per share.
Kort Schnabel framed the quarter as solid and emphasized that the portfolio remains healthy, with borrower cash flow supporting credit performance and stable NAV. His main strategic message was that the MFIC acquisition fits ARCC’s long history of using consolidation to build scale, deepen sponsor relationships, and improve long-term origination capability. He sounded confident that the business enters the seasonally strong fourth quarter from a position of financial strength and that the current dividend remains well supported.
Scott Lem highlighted the financial improvement in GAAP earnings, the slight step-down in core EPS, and the balance-sheet strength behind the company’s funding strategy. He noted $29.2 billion of portfolio fair value, $19.31 NAV per share, net leverage of 1.06x, about $7 billion of available liquidity pro forma for the quarter-end trade payable, and no unsecured notes maturities for the rest of 2026 with $1.4 billion due in 2027. He also pointed to financing actions that lowered costs, including $750 million of 7-year unsecured notes due in 2033 at 185 basis points over treasuries, a reset securitization that cut the weighted average spread by 35 basis points, and commercial paper borrowing that saved about 70 basis points versus the revolver on average balances.
Analysts focused heavily on the MFIC acquisition, asking about the source of the discount, whether the deal could be repeated elsewhere, and how it might affect leverage, nonaccruals, and funding. Management said the discount was concentrated in a small portion of investments with more uncertain outcomes, and that Ares management’s cash consideration helped ARCC buy assets at an even deeper discount while still giving MidCap shareholders a premium. On leverage and funding, management said the transaction is not large enough to change ARCC’s broader leverage or funding strategy, that the financing commitment is effectively a backstop, and that the company may use Ivy Hill Asset Management for some minority participations but had not finalized allocations.
The call presented a business with stable credit, strong liquidity, and improving earnings sensitivity to higher base rates. Management also described a robust opportunity set, with $2.5 billion of backlog, $1.1 billion of fourth-quarter closings already done, and a portfolio that remains diversified and performing well. The MFIC acquisition was framed as both strategically useful and immediately modestly accretive, with added scale and relationship depth.
Origination activity slowed in the quarter, and management acknowledged that this was partly due to being more selective in a volatile environment and partly due to a slower deal market. The MFIC deal is not transformative in size, so while it adds scale, the near-term financial accretion is expected to be only modest. Management also noted that some portfolio companies could become more stressed if base rates remain elevated, even though they do not see a meaningful issue at present.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.4%
- Shares Outstanding
- 722.19M
- Float Shares
- 717.93M
of shares held by institutions
817 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for ARCC, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Pete SessionsHouse · TX17 | Sell | Jul 24, 26 | Filing → |
| Ashley Brooke MoodySenate | Buy | Apr 4, 25 | Filing → |
| Pete SessionsHouse · TX17 | Sell | Nov 1, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Oct 6, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Aug 15, 23 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Jul 14, 23 | Filing → |
| Zoe LofgrenHouse · CA18 | Sell | May 25, 23 | Filing → |
| Thomas Richard CarperSenate · DE | Sell | Jan 18, 22 | Filing → |
| Zoe LofgrenHouse · CA19 | Buy | Sep 2, 21 | Filing → |
| Thomas Richard CarperSenate · DE | Sell | Jul 9, 20 | Filing → |
| Thomas Richard CarperSenate · DE | Buy | Apr 2, 20 | Filing → |
| Pete SessionsHouse · TX17 | Buy | Apr 20, 21 | Filing → |
| Thomas Richard CarperSenate · DE | Sell | Jul 9, 20 | Filing → |
| Thomas Richard CarperSenate · DE | Buy | Apr 2, 20 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 15.65M | ▼ 1.37M |
| Ubs Group AG | 13.75M | ▼ 26.36K |
| Strs Ohio | 12.60M | ▲ 1.94M |
| Van Eck Associates Corp | 11.66M | ▼ 1.64M |
| Bank Of America Corp | 8.94M | ▼ 200.26K |
| Generali Asset Management Spa Sgr | 7.95M | ▲ 402.91K |
| Jpmorgan Chase & Co | 7.88M | ▲ 27.51K |
| Legal & General Group PLC | 6.51M | ▲ 535.29K |
| Two Sigma Investments, LP | 5.89M | ▼ 1.42M |
| Wells Fargo & Company/Mn | 4.44M | ▼ 49.50K |
| Advisors Capital Management, LLC | 4.38M | ▲ 972.56K |
| Ameriprise Financial Inc | 4.12M | ▲ 346.23K |
Held by 64 ETFs
Biggest fund positions in ARCC by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 28, 26 | HENSON MARY BETH | buy | 2,500 |
| Feb 9, 26 | MARKOWICZ JANA | buy | 15,000 |
| Feb 6, 26 | Lem Scott C | buy | 5,186 |
| Feb 5, 26 | HENSON MARY BETH | buy | 4,000 |
| Feb 5, 26 | SCHNABEL MICHAEL KORT | buy | 12,500 |
| Oct 31, 25 | SCHNABEL MICHAEL KORT | buy | 13,000 |
| Sep 30, 25 | Fitzgerald Ian | other | 0 |
| Oct 24, 24 | Miller James Robert | other | 0 |
| Mar 3, 25 | Miller James Robert | buy | 40,000 |
| Feb 18, 25 | Arougheti Michael J | other | 300,172 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ARCC coverage
Recent articles, reports, and earnings notes.

Should You Buy the Runway Growth Finance Corp. IPO? Here's the Setup
Runway Growth Finance Corp. 7.75% Notes Due 2031 are expected to list on NASDAQ on 2026-10-05, but the price range has not been disclosed. This is a debt offering, not an equity IPO, so the key question is whether the coupon and credit profile compensate for the risk. Bull case: a 7.75% fixed-income yield from a specialty finance platform; bear case: noteholders are taking company credit risk and leverage risk.

The Best Private Credit Stocks Right Now (Updated September 2026)
A seven-stock countdown spans direct lending, specialty lending, equipment finance and middle-market credit, with five lower-ranked public private-credit proxies examined in detail.

Nuveen Investment Funds IPO: The Bull and Bear Case
Nuveen Investment Funds, Inc. (NGIF) is expected to list on the NYSE on 2026-06-03, but the price range has not been disclosed. The setup is less a classic IPO and more a fund offering tied to infrastructure exposure. Bull case: a long Nuveen track record and a specialized mandate; bear case: this is not an operating company IPO, and the filing set does not show traditional growth metrics.
Want a deeper read on ARCC?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
4 Yield Traps Paying Over 6% That Retirees Should Watch Out For
247wallst.com · Nov 20
2 Central Banks Of Steady Retirement Cash: 7%+ Yields
seekingalpha.com · Nov 20
5 High-Yield Financial Stocks Boomers Should Buy for December Income
247wallst.com · Nov 19
Roth IRA vs Brokerage Account: 5 High-Yielding Dividend Stocks You Should Never Own Outside a Roth
247wallst.com · Nov 19
Ares Capital Turned $10,000 Into Nearly $31,000 Over 10 Years. Can Its Dividend Do It Again?
fool.com · Nov 18
A December Rate Hike Looks Likely: Buy These 3 Dividend Stocks That Earn More When Rates Rise
247wallst.com · Nov 18
5 Popular Dividend Stocks Yielding Over 7% That Could Cut Their Payouts
247wallst.com · Nov 18
5 “Forever Income” Dividend Stocks Yielding 5% and More for Boomers
247wallst.com · Nov 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.